首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1736744

乳房X光攝影系統市場（按產品類型、技術、最終用戶和地區）：預測（2026-2032 年）

Mammography Systems Market By Product Type, Technology, End User, & Region for 2026-2032

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

乳房X光攝影系統市場評估（2026-2032）

乳癌發生率的上升促使人們日益意識到早期發現和篩檢的重要性，從而推動了乳房X光攝影系統市場的成長。政府支持定期乳房X光攝影檢查的措施和醫療政策，以及新興國家醫療基礎設施的擴張，正在推動市場成長。此外，大眾對早期發現乳癌益處的認知不斷提高，以及預防性保健習慣的養成，也對市場成長做出了重要貢獻。預計乳房X光攝影系統市場規模將在2024年突破24.8億美元的收益，到2032年將達到45.6億美元。

由於旨在早期發現和改善患者預後的技術進步，乳癌市場正在經歷顯著成長。數位乳房乳房X光攝影已取代傳統的膠片系統，提供卓越的影像品質並降低輻射劑量。 3D乳房X光攝影（也稱為數位乳房斷層合成）的引入實現了多層成像，增強了對緻密乳房組織異常的檢測。預計2026年至2032年期間，該市場的複合年成長率將達到7.90%。

乳房X光攝影系統市場定義/概述

乳房X光攝影系統是一種用於拍攝乳房組織詳細影像的診斷工具，主要用於檢測乳癌。該系統使用低劑量X光產生乳房影像，使醫務人員能夠識別組織中的異常或變化。該系統對於篩檢和診斷都至關重要，因為早期發現乳癌可以顯著改善治療效果。

該技術已被醫院、診斷中心和專科診所廣泛採用。檢查過程中，乳房夾在兩塊板之間，X光照射到組織中。產生的影像用於分析是否有腫瘤或其他異常徵兆。該領域的進步促成了數位和3D乳房X光攝影的引入，從而提高了影像品質和準確性，尤其是在乳房組織緻密的情況下。

乳房X光攝影系統的未來預計將專注於進一步的技術進步，例如人工智慧 (AI) 和增強影像處理技術的整合。目前正在開發的 AI 演算法旨在幫助放射科醫生更準確地檢測早期乳癌。

技術進步和政府措施如何促進乳癌乳房X光攝影系統的需求不斷成長？

數位和3D乳房X光攝影等技術進步提高了乳癌檢測的準確性和效率。與傳統的底片系統相比，數位乳房X光攝影可提供更高的影像品質和更少的輻射曝射量。 3D乳房X光攝影（數位乳房乳房X光攝影）的引入實現了多層成像，從而提高了對緻密乳房組織異常的檢測能力。這些技術創新使乳房X光攝影系統更加有效，對醫護人員和患者都更具吸引力。

政府舉措在推廣定期篩檢和提供指導方針以支持使用乳房X光攝影進行早期癌症檢測方面發揮著重要作用。公共衛生計畫通常包括提供資金和資源，以增加乳房X光攝影的可近性，尤其是在醫療資源匱乏的地區。這些政策鼓勵定期篩檢，提高早期發現率，並推動對先進乳房X光攝影技術的需求。

醫療保健提供者在採用新的乳房X光攝影技術時面臨哪些障礙？這些挑戰如何影響患者結果和系統表現？

醫療保健機構在採用新的乳房X光攝影技術時面臨許多障礙。高昂的成本是一大挑戰，因為像3D乳房X光攝影這樣的先進乳房X光攝影系統需要大量資金來購買、安裝和維護。這些高成本可能會限制這些技術的普及，尤其是在資源匱乏或偏遠地區的醫療保健機構。

培訓和專業知識也是重要議題。新技術通常需要對放射科醫生和技術人員進行額外培訓，以確保準確使用和解讀結果。訓練不足會導致表現不佳，影響診斷準確性。與現有系統的整合也是一個挑戰。新的乳房X光攝影系統需要與現有的醫療IT基礎設施相容，包括電子健康記錄(EHR)和診斷影像系統。整合問題可能會妨礙無縫的工作流程和資料管理，而這對於有效的患者照護至關重要。

先進技術的引入可能會影響患者的舒適度和診療可及性。雖然新系統可以提供更優質的影像，但它們也可能需要更長的診療時間或額外的步驟，從而影響患者的舒適度和診療可及性。

The rising prevalence of breast cancer is increasing awareness and the need for early detection and screening, driving growth in the mammography systems market. Government initiatives and healthcare policies supporting routine mammograms, together with the expansion of healthcare infrastructure in emerging nations, have accelerated market growth. Furthermore, greater public awareness of the benefits of early breast cancer detection, as well as increased adoption of preventative healthcare practices, all contribute considerably to market growth. The mammography systems market is estimated to surpass a revenue of USD 2.48 Billion in 2024 and reach USD 4.56 Billion by 2032.

The market has experienced substantial growth, driven by technological advancements aimed at improving early breast cancer detection and patient outcomes. Digital mammography has largely replaced traditional film-based systems, offering superior image quality and reduced radiation exposure. The introduction of 3D mammography, also known as digital breast tomosynthesis, allows for multi-layered imaging, enhancing the detection of abnormalities in dense breast tissue. The market is anticipated to grow at a CAGR of 7.90% from 2026 to 2032.

Mammography Systems Market: Definition/ Overview

Mammography systems are diagnostic tools used to capture detailed images of breast tissue, primarily for the detection of breast cancer. These systems use low-dose X-rays to produce images of the breast, enabling healthcare professionals to identify abnormalities or changes in the tissue. The systems are essential in both screening and diagnostic procedures, where early detection of breast cancer significantly improves treatment outcomes.

The technology is widely employed in hospitals, diagnostic centers, and specialized clinics. During the procedure, the breast is compressed between two plates, and X-rays are passed through the tissue. The images produced are analyzed for signs of tumors or other irregularities. Advances in the field have introduced digital and 3D mammography, which offer improved image quality and accuracy, especially in dense breast tissue.

The future of mammography systems is anticipated to focus on further technological advancements, such as artificial intelligence (AI) integration and enhanced imaging techniques. AI algorithms are being developed to assist radiologists in detecting early-stage breast cancer with greater precision.

How Do Technological Advancements and Government Initiatives Contribute to the Increasing Demand for Mammography Systems in Breast Cancer Detection?

Technological advancements such as the development of digital mammography and 3D mammography have improved the accuracy and efficiency of breast cancer detection. Digital mammography offers higher image quality and lower radiation exposure compared to traditional film-based systems. The introduction of 3D mammography, or digital breast tomosynthesis, enables multi-layered imaging, which enhances the detection of abnormalities in dense breast tissue. These innovations have made mammography systems more effective and appealing for both healthcare providers and patients.

Government initiatives play a crucial role by promoting routine screening and providing guidelines that support the use of mammography for early cancer detection. Public health programs often include funding and resources to make mammography accessible, especially in underserved areas. Such policies encourage regular screenings, which increase early detection rates and drive demand for advanced mammography technologies.

What Obstacles do Healthcare Providers Encounter when Implementing New Mammography Technologies, and how do these Challenges Affect Patient Outcomes and System Performance?

Healthcare providers face several obstacles when implementing new mammography technologies, which can impact patient outcomes and system performance. High costs are a significant challenge, as advanced mammography systems, such as 3D mammography, require substantial financial investment for purchase, installation, and maintenance. This high cost can limit the availability of these technologies, particularly in underfunded or rural healthcare settings.

Training and expertise are also crucial issues. New technologies often necessitate additional training for radiologists and technicians to ensure accurate usage and interpretation of results. Insufficient training can lead to suboptimal performance and potentially affect diagnostic accuracy. Integration with existing systems poses another challenge. New mammography systems need to be compatible with existing healthcare IT infrastructure, including electronic health records (EHRs) and imaging systems. Integration issues can hinder the seamless workflow and data management essential for effective patient care.

Patient comfort and access can be affected by the introduction of advanced technologies. While new systems offer better imaging, they may also require longer procedures or additional steps that impact patient comfort and accessibility.

Category-Wise Acumens

What are the Key Advantages of Full-Field Digital Mammography over Analog Mammography Systems in Breast Cancer Detection?

Full-field mammography segment significantly dominates the mammography systems market. Full-field digital mammography (FFDM) provides significant advantages over Analog Mammography Systems in breast cancer detection. FFDM offers superior image quality with higher resolution and greater detail, enabling better visualization of small or subtle abnormalities. This enhanced clarity improves diagnostic accuracy. FFDM typically requires lower radiation doses, reducing patient exposure while still maintaining effective screening results. The faster image acquisition and processing times associated with digital systems enhance efficiency, reducing the time patients spend in imaging and allowing for quicker diagnosis.

The digital images can be easily manipulated, such as adjusting contrast and brightness, which assists radiologists in detecting and analyzing potential issues more effectively. These benefits collectively make FFDM a more advanced and effective tool for breast cancer detection compared to traditional analog mammography systems.

What Factors Influence the Choice of Mammography Systems in Diagnostic Centers Compared to Hospitals, and how do these Factors Affect their Implementation and Patient Outcomes?

The choice of mammography systems in diagnostic centers compared to hospitals is influenced by various factors affecting their implementation and patient outcomes. Cost and budget constraints often drive diagnostic centers to select cost-effective systems that provide a balance between quality and affordability. In contrast, hospitals with larger budgets might invest in the latest advanced technologies, such as 3D mammography systems, to offer comprehensive services. The volume of patients plays a role; hospitals, managing higher patient loads, may require high-capacity systems for efficiency, while diagnostic centers, which focus on specialized screenings, might choose high-resolution systems for detailed analysis.

Space and infrastructure are also considerations, with diagnostic centers opting for more compact or versatile systems due to limited space, whereas hospitals can accommodate larger systems and integrate them into extensive imaging departments. Finally, diagnostic centers may prioritize state-of-the-art technologies due to their specialization in mammography, while hospitals integrate mammography with a broader range of diagnostic modalities.

What Factors Contribute to North America's Leadership In the Mammography Systems Market, and how do these Factors Influence the Adoption of Advanced Technologies In the Region?

North America significantly dominates the mammography systems and it is expected to maintain throughout the forecast period driven by the United States, the largest economy in North America, which generates the majority of the market's revenue. High healthcare spending in countries like the United States and Canada supports the acquisition of advanced mammography systems and funds comprehensive screening programs. The region's well-established healthcare infrastructure, including state-of-the-art medical facilities, is well-equipped to integrate and utilize advanced technologies such as digital and 3D mammography.

Government initiatives also play a crucial role in robust public health campaigns and policies promoting early breast cancer detection driving demand for advanced systems. North America is a leader in technological innovation, being at the forefront of developing and implementing cutting-edge mammography technologies that enhance diagnostic accuracy and patient outcomes. These factors together ensure that North America remains a global leader in the mammography systems market, influencing both technology adoption and market expansion.

How is the Adoption of Mammography Systems Evolving in the Asia-Pacific Region?

The Asia-Pacific region is anticipated to experience the fastest growth in the mammography systems market during the forecast period driven by rapid economic growth in countries is leading to increased healthcare investment, which supports the procurement of advanced medical technologies, including mammography systems. The expansion of healthcare infrastructure and the development of new healthcare facilities are making sophisticated diagnostic tools more accessible. Government initiatives aimed at improving cancer screening and early detection, particularly in emerging economies, are also driving market growth. Public health campaigns and increased awareness about breast cancer are contributing to higher demand for mammography services.

The partnerships between international companies and local healthcare providers are facilitating the introduction and expansion of advanced mammography technologies in the region. These collaborative efforts help address disparities in access to quality screening services and support the implementation of digital and 3D mammography systems. The Asia-Pacific region is experiencing a notable increase in the adoption of mammography systems, driven by economic development, healthcare expansion, and a growing emphasis on early cancer detection.

Competitive Landscape

The competitive landscape of the Mammography Systems Market is dynamic and constantly evolving. New players are entering the market, and existing players are investing in research and development to maintain their competitive edge. The market is characterized by intense competition, rapid technological advancements, and a growing demand for innovative and efficient solutions.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the mammography systems market include:

Philips N.V.
General Electric Company
Analogic Corporation
Carestream Health, Inc.
Planmed Oy
Delphinus Medical Technologies
Fujifilm Holdings Corporation
Hologic, Inc.
IMS Giotto S.P.A
Konica Minolta Inc.

Latest Developments

In April 2024, Hologic Inc. has announced its acquisition of Endomag, a breast care company, for $310 million. This acquisition aims to expand Hologic's breast surgery portfolio with Endomag's technologies, including the Magseed marker for magnetic tissue localization, Magtrace injectable for lymphatic tracing in breast cancer staging, and the Sentimag platform. These additions will enhance options for surgeons and radiologists, catering to the specific needs of patients undergoing critical breast cancer procedures.
In December 2024, Lunit, a medical AI company, has agreed to acquire Volpara Health Technologies, based in New Zealand and known for its AI-powered software for early detection of breast cancer.

Mammography Systems Market, By Category

Product Type:
Full-Field Digital Mammography
Analog Mammography Systems
Breast Tomosynthesis Systems
Technology:
Screen-Film Mammography
Digital Mammography

3D Mammography

End-User:
Hospitals
Diagnostic Centers
Specialty Clinics
Region:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

1 INTRODUCTION OF GLOBAL MAMMOGRAPHY SYSTEMS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MAMMOGRAPHY SYSTEMS OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY

5.1 Overview
5.2 Screen-Film Mammography
5.3 Digital Mammography
5.4 3D Mammography

6 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Full-Field Digital Mammography
6.3 Analog Mammography Systems
6.4 Breast Tomosynthesis Systems

7 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY END USER

7.1 Overview
7.2 Hospitals
7.3 Diagnostic Centers
7.4 Specialty Clinics

8 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL MAMMOGRAPHY SYSTEMS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Philips N.V
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 General Electric Company
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Analogic Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Carestream Health Inc.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Fujifilm Holdings Corporation
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Delphinus Medical Technologies
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Hologic Inc
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Planmed Oy
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 IMS Giotto S.P.A
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Konica Minolta Inc
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments